Teleflex handed class I notice over IV recall
This article was originally published in Clinica
Teleflex’s recall of its custom intravenous (IV) administration products has been given a class I notification by the FDA – the most serious type of recall notice. The faulty products include IV tubing sets and accessories manufactured by the firm’s Arrow International subsidiary from 2000 through 2009 and distributed prior to 19 February 2010. Teleflex (Limerick, Pennsylvania) discovered pin holes or punctures in the products’ packaging that could cause “blood-borne or other types of infections, which could result in serious injury or death”. The tubing sets are used to transfer fluids from a container to a patient’s blood vessel system.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals